Wang G, Zhang E, Chen A, Meng D
PeerJ. 2024; 12:e18296.
PMID: 39465162
PMC: 11505884.
DOI: 10.7717/peerj.18296.
Cai W, Tanaka K, Mi X, Rajasekhar V, Khan J, Yoo S
Cancer Immunol Res. 2024; 12(10):1361-1379.
PMID: 38959337
PMC: 11444887.
DOI: 10.1158/2326-6066.CIR-24-0246.
Ciura P, Smardz P, Spodzieja M, Sieradzan A, Krupa P
J Phys Chem B. 2024; 128(28):6770-6785.
PMID: 38958133
PMC: 11264271.
DOI: 10.1021/acs.jpcb.4c02255.
Dalle S, Verronese E, NKodia A, Bardin C, Rodriguez C, Andrieu T
Oncoimmunology. 2024; 13(1):2372118.
PMID: 38939518
PMC: 11210932.
DOI: 10.1080/2162402X.2024.2372118.
Pulliam L, Sun B, McCafferty E, Soper S, Witek M, Hu M
Int J Mol Sci. 2024; 25(7).
PMID: 38612641
PMC: 11011771.
DOI: 10.3390/ijms25073830.
Advances in tumor microenvironment and underlying molecular mechanisms of bladder cancer: a systematic review.
Tang L, Xu H, Wu T, Wu W, Lu Y, Gu J
Discov Oncol. 2024; 15(1):111.
PMID: 38602556
PMC: 11009183.
DOI: 10.1007/s12672-024-00902-8.
CD169 classical monocyte as an important participant in Graves' ophthalmopathy through CXCL12-CXCR4 axis.
Wang D, Ling J, Tan R, Wang H, Qu Y, Li X
iScience. 2024; 27(3):109213.
PMID: 38439953
PMC: 10910260.
DOI: 10.1016/j.isci.2024.109213.
Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy.
Sordo-Bahamonde C, Lorenzo-Herrero S, Granda-Diaz R, Martinez-Perez A, Aguilar-Garcia C, Rodrigo J
Mol Cancer. 2023; 22(1):142.
PMID: 37649037
PMC: 10466776.
DOI: 10.1186/s12943-023-01845-4.
LIGHT (TNFSF14) promotes the differentiation of human bone marrow-derived mesenchymal stem cells into functional hepatocyte-like cells.
Heo S, Yu H, Kim D, Seo H, Shin Y, Kim S
PLoS One. 2023; 18(8):e0289798.
PMID: 37552689
PMC: 10411951.
DOI: 10.1371/journal.pone.0289798.
Tumor Necrosis Factor Superfamily 14 (LIGHT) Restricts Neovascularization by Decreasing Circulating Endothelial Progenitor Cells and Function.
Hsu C, Huang C, Shih C, Lin Y, Huang P, Lin S
Int J Mol Sci. 2023; 24(8).
PMID: 37108160
PMC: 10138919.
DOI: 10.3390/ijms24086997.
T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis.
Zheng C, Shi Y, Zou Y
Front Immunol. 2023; 14:1081999.
PMID: 36993982
PMC: 10040887.
DOI: 10.3389/fimmu.2023.1081999.
Serum Immune Profiling in Paediatric Crohn's Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both Treatments.
Jongsma M, Costes L, Tindemans I, Cozijnsen M, Raatgreep R, van Pieterson M
J Crohns Colitis. 2023; 17(8):1262-1277.
PMID: 36934327
PMC: 10441564.
DOI: 10.1093/ecco-jcc/jjad049.
Landscape of costimulatory molecule signature in breast cancer and its prognostic significance.
Kang C, Yun F, Shi L, Jia Y, Liu X
Ann Transl Med. 2023; 11(2):59.
PMID: 36819560
PMC: 9929799.
DOI: 10.21037/atm-22-6245.
Discovery and Validation of a SIT1-Related Prognostic Signature Associated with Immune Infiltration in Cutaneous Melanoma.
Jia M, Liu C, Liu Y, Bao Z, Jiang Y, Sun X
J Pers Med. 2023; 13(1).
PMID: 36675674
PMC: 9866779.
DOI: 10.3390/jpm13010013.
A novel diagnostic model for predicting immune microenvironment subclass based on costimulatory molecules in lung squamous carcinoma.
Duan F, Wang W, Zhai W, Wang J, Zhao Z, Zheng L
Front Genet. 2023; 13:1078790.
PMID: 36588791
PMC: 9795004.
DOI: 10.3389/fgene.2022.1078790.
A Deficiency in the Cytokine TNFSF14/LIGHT Limits Inflammation and Remodeling in Murine Eosinophilic Esophagitis.
Manresa M, Miki H, Miller J, Okamoto K, Dobaczewska K, Herro R
J Immunol. 2022; .
PMID: 36288906
PMC: 10130236.
DOI: 10.4049/jimmunol.2200326.
Characterization of sepsis inflammatory endotypes using circulatory proteins in patients with severe infection: a prospective cohort study.
Ricano-Ponce I, Riza A, de Nooijer A, Pirvu A, Dorobantu S, Dragos A
BMC Infect Dis. 2022; 22(1):778.
PMID: 36209073
PMC: 9547371.
DOI: 10.1186/s12879-022-07761-0.
Revealing the characteristics of ZIKV infection through tissue-specific transcriptome sequencing analysis.
Chen Z, Yin Z, Qiu T, Chen J, Liu J, Zhang X
BMC Genomics. 2022; 23(1):697.
PMID: 36209057
PMC: 9546753.
DOI: 10.1186/s12864-022-08919-5.
The Neonatal Innate Immune Response to Sepsis: Checkpoint Proteins as Novel Mediators of This Response and as Possible Therapeutic/Diagnostic Levers.
Hensler E, Petros H, Gray C, Chung C, Ayala A, Fallon E
Front Immunol. 2022; 13:940930.
PMID: 35860251
PMC: 9289477.
DOI: 10.3389/fimmu.2022.940930.
LCMV induced downregulation of HVEM on antiviral T cells is critical for an efficient effector response.
Diethelm P, Schmitz I, Iten I, Kisielow J, Matsushita M, Kopf M
Eur J Immunol. 2022; 52(6):924-935.
PMID: 35344223
PMC: 9321772.
DOI: 10.1002/eji.202048569.